Congleton Jon

Avg. Two Year Performance

(44%) Avg. Purchase Return
(20%) Compound
No sale track record
1 Mo3 Mo6 Mo1 Yr2 Yr
Average Purchase Return< 1%(< 1%)11%(42%)(44%)
Purchase Success Rate2 of 41 of 41 of 40 of 40 of 4
Average Sale Return0%0%0%0%0%
Sale Success Rate0 of 30 of 30 of 30 of 30 of 3

Nivalis Therapeutics, Inc.

Drugs » Biotechnology

President and CEO, Director:

Holdings: 20.0K shares

Sentiment

Insider Trading Sentiment: Hold

Avg. Two Year Performance

No purchase track record
No sale track record

Last Three Months:

0 Net Amount
Buy:0--
Sell:0--

Mineralys Therapeutics, Inc.

Other » Other

Chief Executive Officer, Director:

Holdings: 895.94K shares

Sentiment

Insider Trading Sentiment: Hold

Avg. Two Year Performance

No purchase track record
No sale track record

Last Three Months:

($206.43K) Net Amount
Buy:0--
Sell:($206.43K)$13.52